The Robin Study
Pivotal trial evaluating an oral therapeutic candidate in the treatment of postpartum depression.
This research study is evaluating the safety and effectiveness of SAGE-217, an investigational oral medication, in women with postpartum depression (PPD). For more information about this trial and participating locations, visit the Robin Study website.
We are committed to respecting the primary role of healthcare providers in the treatment of CNS disorders. Therefore, we cannot respond to medical questions about your personal health situation, nor can we accept private medical information. Please contact your healthcare provider with any questions pertaining to your or a family member’s medical condition.